A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients

NCT00446069 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain
Cancer

Interventions

DRUG: Morphine Sulphate

Sponsor

Egalet Ltd